HOME >> BIOLOGY >> NEWS
NJIT professor to address Water Industry Conference At Harvard Club about desalinating water

Chemical engineer Kamalesh Sirkar, PhD, a distinguished professor at New Jersey Institute of Technology (NJIT) will discuss Thursday new technologies for desalinating and treating water. Sirkar, an expert in membrane separation technology whose work is supported by grants from the US Department of the Interior and US Office of Naval Research, speaks at 4:30 p.m., June 8, 2006, at the Harvard Club, 27 West 44th Street, NYC. The daylong conference, sponsored by The Wall Street Transcript, will offer businessmen, engineers and others an overview of ways to profit in the water industry.

(Note to Editors: To interview Sirkar, contact Sheryl Weinstein, 973-596-3436.)

Sirkar, who is now researching an exciting breakthrough method to desalinate sea or brackish water, holds more than 20 patents in the field of membrane separation. Using his desalination technology, engineers will be able to recover water from brines with the highest salt concentrations. His talk will touch on this new and upcoming research.

Sirkar will also discuss the newest advances in heat exchangers as well as what's new in reverse osmosis. He will highlight the work of four other NJIT professors in the departments of chemistry, and civil and environmental engineering, who are also working to bring higher levels of potable water to communities in the US and around the world.

Sirkar's distillation process has been especially notable because once ready, it will work with brines holding salt concentrations above 5.5 percent. Currently, 5.5 percent is the highest percentage of salt in brine that can be treated using reverse osmosis.

"We especially like our new process because we can fuel it with low-grade, inexpensive waste heat," Sirkar said. "Cheap heat costs less and heats brine efficiently."

The science behind Sirkar's membrane distillation process is simple. The inexpensive fuel heats the water, forcing it to evaporate from the salt solution.
'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
6-Jun-2006


Page: 1 2 3

Related biology news :

1. Decorated UH professor to help choose nations top scientists
2. UCF professor finds bacterial pathogen may be key to understanding cancer development
3. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
4. 2 MSU professors spearhead international water project
5. WPI professor to represent American Mathematical Society at exhibition on science funding
6. NJIT professor says certain home shapes and roofs hold up best in hurricane
7. Dartmouth professor makes case for ethically universal stem cell lines
8. Computer science professor awarded $400,000 from National Science Foundation
9. FSU engineering professor growing bone in a lab
10. LSU professor involved in genome sequencing of the first marsupial
11. 5 Stanford professors elected to National Academy of Sciences

Post Your Comments:
(Date:5/20/2013)... new study conducted at the University of Bristol and ... Biology sheds light on how the brain and ... from Bristol,s School of Earth Sciences, together with Tom ... the brains of 150 million year old dinosaurs. , ... dinosaur Dysalotosaurus lettowvorbecki : a very young (juvenile) ...
(Date:5/19/2013)... engineered a strain of electricity-producing bacteria that can grow ... carbon dioxide as its sole source of carbon. ... findings at the 113th General Meeting of the American ... of current production solely on hydrogen," says Amit Kumar, ... co-authors are part of the Lovley Lab Group at ...
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
Breaking Biology News(10 mins):Fossil brain teaser 2Coffee consumption associated with reduced risk of autoimmune liver disease 2
(Date:5/21/2013)... , May 21, 2013 ... Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services ... Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, ... in 2011 and is expected to grow at a ... an estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Revolutionary Science, ... automatic colony counter, announced today that they have expanded ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... sophistication are especially useful in food microbiology and pharmaceutical ... an updated look. A bright white enclosure with ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 Possible mold ... And so, according to a report from eagletribune.com posted May ... mold. In case the result is positive, My Cleaning Products ... using harmful chemical ingredients. , It was said in the ... re-infestation in the campus sparked after a first-grade classroom ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
Cached News: